Tilray Inc (TLRY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $359.12M
Last updated: Nov 17, 2026 at 11:06 AM ET
Tilray Inc (TLRY) Stock Forecast
Analysts expect Tilray (TLRY) to earn -$0.13 per share in the fiscal year ending May 31, 2027, on revenue of $1.10B. Of 10 analysts, 3 rate the stock Buy or Strong Buy, 7 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending May 31, 2027 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.70, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 30% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 30.0% |
| Hold | 7 | 70.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 10
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 5.5%.
- Fiscal year ending May 31, 2027
- -$0.13
- EPS consensus, revenue $1.10B
- Fiscal year ending May 31, 2028
- $0.14
- EPS consensus, revenue $1.16B
- Next report
- Jan 6, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| May 31, 2027 | -$0.13 | -$0.36 to $0.10 | 2 | $1.10B | $1.07B to $1.13B | 10 |
| May 31, 2028 | $0.14 | -$0.11 to $0.39 | 2 | $1.16B | $1.11B to $1.20B | 9 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| May 31, 2027 | -$0.02 | -$0.08 to $0.00 | 8 | $321.91M | $286.16M to $382.41M | 11 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending May 31, 2027 | 0 | 1 |
| Fiscal year ending May 31, 2028 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending May 31, 2027 has turned from a profit of $0.26 to a loss.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending May 31, 2027 | -$0.13 | $0.06 | $0.07 | $0.26 | $0.26 | N/A |
| Fiscal year ending May 31, 2028 | $0.14 | $0.18 | $0.18 | $0.45 | $0.74 | -80.8% |
Frequently Asked Questions About TLRY
What is the TLRY stock forecast?
Consensus analyst estimates put Tilray's EPS at -$0.13 for the fiscal year ending May 31, 2027, on revenue of $1.10B. The consensus rating from 10 analysts is Hold.
How do analysts rate TLRY stock?
Of 10 analysts covering Tilray, 0 rate it Strong Buy, 3 Buy, 7 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from TLRY next year?
For the fiscal year ending May 31, 2027, the consensus EPS estimate is -$0.13, with estimates from -$0.36 to $0.10 from 2 analysts. For the fiscal year ending May 31, 2028, the consensus EPS estimate is $0.14, with estimates from -$0.11 to $0.39 from 2 analysts.
What revenue do analysts expect from Tilray next year?
For the fiscal year ending May 31, 2027, the consensus revenue estimate is $1.10B, with estimates from $1.07B to $1.13B. For the fiscal year ending May 31, 2028, the consensus revenue estimate is $1.16B, with estimates from $1.11B to $1.20B.
How many analysts cover TLRY?
10 analysts rate Tilray stock, and 2 analysts estimate its EPS for the fiscal year ending May 31, 2027.
TLRY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors